VERU INC. Business Finance Contracts & Agreements
55 Contracts & Agreements
- Credit Agreements (6 contracts)
- Escrow Agreements (1)
- Forbearance Agreements (1)
- Guarantee Agreements (1)
- Loan Agreements (13)
- Note Agreements (5)
- Pledge Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (4)
- Security Agreements (3)
- Share Agreements (1)
- Stock Agreements (11)
- Underwriting Agreements (3)
- Warrant Agreements (1)
- Amended and Restated Forbearance Agreement and Amendment to September 2024 Note, dated as of September 19, 2024, between Veru Inc. and Onconetix, Inc (Filed With SEC on September 20, 2024)
- Forbearance Agreement, dated as of April 24, 2024, between Veru Inc. and Onconetix, Inc (Filed With SEC on April 26, 2024)
- Underwriting Agreement dated December 14, 2023, by and between Veru Inc. and the underwriters named therein (Filed With SEC on December 18, 2023)
- Description of Capital Stock (Filed With SEC on December 8, 2023)
- Amendment to Asset Purchase Agreement, dated as of September 29, 2023, between Veru Inc. and Blue Water Biotech Inc (Filed With SEC on October 2, 2023)
- Registration Rights Agreement dated May 2, 2023 by and between the Company and Lincoln Park (Filed With SEC on May 3, 2023)
- Purchase Agreement dated May 2, 2023 by and between the Company and Lincoln Park (Filed With SEC on May 3, 2023)
- Asset Purchase Agreement, dated as of April 19, 2023, between Veru Inc. and Blue Water Vaccines Inc (Filed With SEC on April 20, 2023)
- Stock Purchase Agreement, dated as of April 12, 2023, between Veru Inc. and Frost Gamma Investments Trust (Filed With SEC on April 13, 2023)
- Description of Capital Stock (Filed With SEC on December 5, 2022)
- Description of Capital Stock (Filed With SEC on December 2, 2021)
- Underwriting Agreement dated February 17, 2021, by and between Veru Inc. and Jefferies LLC, as representative of the underwriters named therein (Filed With SEC on February 18, 2021)
- Third Amendment to Credit Agreement, dated as of October 5, 2020, among the Company, SWK Funding LLC and the financial institutions party thereto from time to time (Filed With SEC on December 10, 2020)
- Description of Capital Stock (Filed With SEC on December 10, 2020)
- Asset Purchase Agreement, dated as of December 8, 2020, between the Company and Roman Health Ventures Inc (Filed With SEC on December 10, 2020)
- Registration Rights Agreement, dated as of June 26, 2020, between Veru Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 26, 2020)
- Common Stock Purchase Agreement, dated as of June 26, 2020, between Veru Inc. and Aspire Capital Fund, LLC (Filed With SEC on June 26, 2020)
- Description of Capital Stock (Filed With SEC on December 12, 2019)
- Second Amendment to Credit Agreement & Amendment to Residual Royalty Agreement, dated as of May 13, 2019, among the Company, SWK Funding LLC and the financial institutions party... (Filed With SEC on May 15, 2019)
- Underwriting Agreement dated September 27, 2018, by and between Veru Inc. and Cantor Fitzgerald & Co., as representative of the underwriters named therein (Filed With SEC on September 27, 2018)
- First Amendment to Credit Agreement, dated as of August 10, 2018, among the Company, SWK Funding LLC and the financial institutions party to the Credit Agreement from time to time (Filed With SEC on August 14, 2018)
- Pledge Agreement, dated as of March 5, 2018, between the Company and the Agent (Filed With SEC on March 6, 2018)
- Intellectual Property Security Agreement, dated as of March 5, 2018, between the Company and the Agent (Filed With SEC on March 6, 2018)
- Guarantee and Collateral Agreement, dated as of March 5, 2018, between the Company and the Agent (Filed With SEC on March 6, 2018)
- Credit Agreement, dated as of March 5, 2018, among the Company, the Agent and the Lenders party thereto from time to time (Filed With SEC on March 6, 2018)
- Registration Rights Agreement, dated as of December 29, 2017, between the Company and Aspire Capital Fund, LLC (Filed With SEC on January 2, 2018)
- Common Stock Purchase Agreement, dated as of December 29, 2017, between the Company and Aspire Capital Fund, LLC (Filed With SEC on January 2, 2018)
- THE FEMALE HEALTH COMPANY STOCK APPRECIATION RIGHTS AGREEMENT (Filed With SEC on February 9, 2017)
- THE FEMALE HEALTH COMPANY RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on February 9, 2017)
- Second Amendment to Security Agreement and First Amendment to Subsidiary Security Agreement (Filed With SEC on December 12, 2016)
- First Amendment and Waiver to Credit Agreement and Security Agreement (Filed With SEC on December 12, 2016)
- WARRANT To Subscribe for andPurchase Common Stock of THE FEMALE HEALTH COMPANY (Filed With SEC on November 2, 2016)
- ESCROW AGREEMENT (Filed With SEC on November 2, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 2, 2016)
- Consent and Amendment to Credit Agreement (Filed With SEC on July 28, 2016)
- FOURTH AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on December 2, 2015)
- THIRD AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on December 2, 2014)
- SECOND AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on December 3, 2013)
- THE FEMALE HEALTH COMPANY RESTRICTED STOCK GRANT AGREEMENT (Grant No._________) (Filed With SEC on December 3, 2013)
- Exhibit10.11 FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on December 4, 2012)
